Stock Upgrades Today Driving Market Buzz and Gains

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  25 Aug 2025
 

•   CHRD  
   
  0.00%
•   CMCO  
   
  0.00%
•   COP  
   
  0.00%
•   FE  
   
  0.00%
•   HLN  
   
  0.00%

$CHRD gained attention today as UBS maintained a Buy rating and lifted the price target to $122. Investors are reacting positively to the reaffirmed confidence in the company’s growth prospects, with the stock showing modest upward movement as traders anticipate continued energy sector strength.

$CMCO saw a notable upgrade today tied to its long-term expansion strategy and growing clinical footprint. The addition of Dr. Ahmed Toure to its Manhattan team signals a commitment to enhanced patient care and operational growth, positioning the company for potential upside in both revenue and market perception.

$COP received a reaffirmed Buy rating from Roth MKM, with a price target of $108. The upgrade underscores the firm’s stable performance in the energy sector and ongoing opportunities for returns as oil and gas demand remains resilient.

$FE was upgraded by Barclays, highlighting management’s undervalued growth plan. The market responded to the potential for stronger earnings driven by utility modernization and efficiency initiatives, making the stock a focus for traders seeking utility sector opportunities.

$HLN maintained its Buy rating despite a slight price target adjustment. The upgrade reflects confidence in the company’s core product portfolio and its ability to navigate market pressures, providing traders with steady growth potential.

$HUBS attracted an upgrade as subscription revenues jumped 16% in Q2, fueled by AI-driven product enhancements and new customer acquisition. Investors are eyeing the company’s ability to sustain momentum through innovation and market expansion.

$INFY shares gained traction after upgrades from Investec and JP Morgan, with analysts citing AI-led transformation, cost efficiency, and robust order books as key drivers. The stock’s modest gains highlight long-term resilience in IT services.

$JNJ was highlighted as a buy amid record Dow highs and upgraded estimates. The stock benefits from diversified growth drivers and strong fundamentals, appealing to investors seeking stability alongside upside potential.

$NMRK saw a Fitch upgrade of its commercial primary servicer rating. The positive rating adjustment reflects confidence in operational execution and financial stability, boosting market sentiment for the stock.

$OKTA received multiple upgrades, including from Truist, raising the price target to $125. With anticipated Q2 results and growing penetration in identity management, traders are bullish on the company’s near-term growth trajectory.

$RIVN Rivian was reaffirmed as a Buy with attention on its upcoming R2 model, projected to expand market share and revenue. Investor sentiment is buoyed by the potential for growth in the mid-size SUV segment and strong brand recognition.

$SLB Schlumberger was initiated as a Buy by Melius Research, signaling confidence in the oilfield services giant’s growth prospects. Traders are encouraged by the company’s operational scale and market positioning.

$SO Southern Company was upgraded as it advances hydro fleet modernization, enhancing efficiency and extending asset life. Investors view these long-term infrastructure investments as a catalyst for sustained performance.

$TEVA Teva Pharmaceutical maintained a Buy rating from Piper Sandler, reinforcing confidence in its pharmaceutical portfolio and growth outlook despite near-term volatility.

$TLRY Tilray surged following a positive note from Jefferies and optimism around cannabis reform in the U.S. The upgrade signals potential regulatory-driven growth and investor enthusiasm for the sector.

$VCEL Vericel sustained its Buy rating from TD Cowen, supported by growth potential in its MACI Arthro product. Investors are watching closely for continued product adoption and revenue expansion.

View All Headlines